Published

23andMe board quits over plans to take DNA testing company private

  • The 23andMe board of directors resigned, stating they differed on the company’s strategic direction and believed resignation was best for the company and its shareholders.
  • Anne Wojcicki expressed surprise and disappointment over the resignations and reaffirmed her commitment to taking 23andMe private.
  • Wojcicki stated that going private would enhance long-term success by reducing short-term pressures from public markets and emphasized her commitment to stakeholders.
Insights by Ground AI
Does this summary seem wrong?

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 58% of the sources are Center
58% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)